| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 29 | 0 | 2000 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 125 | 0 | 1996 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.100 | None | 0.986 | 282 | 2 | 2002 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.600 | None | 0.970 | 544 | 7 | 1989 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.350 | None | 1.000 | 5 | 0 | 2007 | 2019 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.991 | 111 | 0 | 2003 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.100 | None | 0.955 | 22 | 0 | 1997 | 2020 | ||||||||
|
interleukin 4 | 0.332 | 0.962 | 4.7E-03 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 1996 | 2017 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.600 | None | 0.983 | 281 | 2 | 1993 | 2020 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.100 | None | 1.000 | 12 | 0 | 2003 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
phenotype | 0.400 | None | 1.000 | 35 | 0 | 1993 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
phenotype | 0.350 | None | 1.000 | 5 | 2 | 2004 | 2015 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.030 | None | 0.667 | 3 | 0 | 2014 | 2019 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 29 | 3 | 2010 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.959 | 72 | 0 | 1990 | 2019 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.959 | 70 | 0 | 1996 | 2019 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
phenotype | 0.400 | None | 0.971 | 34 | 0 | 1991 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 0.952 | 21 | 0 | 1997 | 2019 | ||||||||
|
leptin | 0.349 | 0.846 | 0.46 |
|
phenotype | 0.100 | None | 0.973 | 35 | 0 | 2003 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
phenotype | 0.100 | None | 0.908 | 65 | 0 | 1994 | 2019 | |||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
phenotype | 0.100 | None | 0.986 | 145 | 5 | 1997 | 2020 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.100 | None | 0.947 | 19 | 0 | 2000 | 2020 | ||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
phenotype | 0.100 | None | 0.939 | 66 | 0 | 1998 | 2020 | |||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
phenotype | 0.100 | None | 0.933 | 15 | 0 | 2001 | 2019 |